chr12-57243810-G-A
Position:
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_145064.3(STAC3):c.*2C>T variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.28 in 1,612,394 control chromosomes in the GnomAD database, including 66,431 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.25 ( 5116 hom., cov: 32)
Exomes 𝑓: 0.28 ( 61315 hom. )
Consequence
STAC3
NM_145064.3 3_prime_UTR
NM_145064.3 3_prime_UTR
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.123
Genes affected
STAC3 (HGNC:28423): (SH3 and cysteine rich domain 3) The protein encoded by this gene is a component of the excitation-contraction coupling machinery of muscles. This protein is a member of the Stac gene family and contains an N-terminal cysteine-rich domain and two SH3 domains. Mutations in this gene are a cause of Native American myopathy. [provided by RefSeq, Nov 2013]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.75).
BP6
Variant 12-57243810-G-A is Benign according to our data. Variant chr12-57243810-G-A is described in ClinVar as [Benign]. Clinvar id is 262568.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.411 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
STAC3 | NM_145064.3 | c.*2C>T | 3_prime_UTR_variant | 12/12 | ENST00000332782.7 | NP_659501.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
STAC3 | ENST00000332782.7 | c.*2C>T | 3_prime_UTR_variant | 12/12 | 2 | NM_145064.3 | ENSP00000329200 | P1 | ||
STAC3 | ENST00000554578.5 | c.*2C>T | 3_prime_UTR_variant | 11/11 | 1 | ENSP00000452068 | ||||
STAC3 | ENST00000557176.5 | c.*157C>T | 3_prime_UTR_variant, NMD_transcript_variant | 8/8 | 1 | ENSP00000450740 | ||||
STAC3 | ENST00000546246.2 | c.*2C>T | 3_prime_UTR_variant | 9/9 | 2 | ENSP00000441515 |
Frequencies
GnomAD3 genomes AF: 0.249 AC: 37856AN: 151976Hom.: 5111 Cov.: 32
GnomAD3 genomes
AF:
AC:
37856
AN:
151976
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.271 AC: 67649AN: 249444Hom.: 10214 AF XY: 0.284 AC XY: 38338AN XY: 135186
GnomAD3 exomes
AF:
AC:
67649
AN:
249444
Hom.:
AF XY:
AC XY:
38338
AN XY:
135186
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.283 AC: 413455AN: 1460300Hom.: 61315 Cov.: 34 AF XY: 0.288 AC XY: 209580AN XY: 726466
GnomAD4 exome
AF:
AC:
413455
AN:
1460300
Hom.:
Cov.:
34
AF XY:
AC XY:
209580
AN XY:
726466
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.249 AC: 37878AN: 152094Hom.: 5116 Cov.: 32 AF XY: 0.256 AC XY: 19020AN XY: 74328
GnomAD4 genome
AF:
AC:
37878
AN:
152094
Hom.:
Cov.:
32
AF XY:
AC XY:
19020
AN XY:
74328
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1020
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Mar 28, 2021 | - - |
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | - | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at